Brief: JCR Pharmaceuticals - To Start Construction On New COVID-19 Vaccine Plant In July, Scheduled Completion In Oct 2022
04/03/2021 05:05
March 4 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T :
* NOTICE OF CONSTRUCTION OF NEW PLANT FOR COVID-19 VACCINE
SOLUTION
* TO START CONSTRUCTION ON NEW COVID-19 VACCINE PLANT FOR
ASTRAZENECA IN JULY, SCHEDULED COMPLETION IN OCT 2022
* TO SPEND ABOUT 11.6 BILLION YEN ON COVID-19 VACCINE PLANT
Source text for Eikon: ID:nTSOD7386b
Further company coverage: 4552.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results